Inhibiting NF-κB can modulate the expression of inflammatory factors to alter the microenvironment, which can also regulate the expression of oncogenes to slow down the progression of GC, and berberine can treat stomach cancer by this (Liu et al., 2022). Here, NFKB1 is linked to gastric cancer.